Search
for
Sort by
Research 751–780 of 1000+
- Epigenetics of Colorectal Cancer
- Estrogens and aging skin
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- PROTACs: A novel strategy for cancer drug discovery and development
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Field Cancerization: From Molecular Basis to Selective Field-Directed Management of Actinic Keratosis
- The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: A review
- Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil
- Ottawa, Ontario, Canada, February 13–16, 2013
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities
- Cold Atmospheric Plasma for Breast Cancer
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot study
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Dynamic changes of gut and skin microbiota in pancreatic cancer-induced skin injury
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Evaluation of Clinical and Oral Findings in Patients with Epidermolysis bullosa
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)